is doing DD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
...On the edge of my seat...
&
effective Oct. 19,2018 Intiva BioPharma Inc., NTVA, will change to Nexien BioPharma Inc., NXEN:
http://otce.finra.org/DLSymbolNameChanges
NTVA name change to NXEN
effective Oct. 19,2018 Intiva BioPharma Inc., NTVA, will change to Nexien BioPharma Inc., NXEN:
In CAD that would be around 26$?
Maybe I'm crazy but there is a dreamer inside that wishes it goes much higher. Maybe I'm living in utopia?
I'm holding everything since the Canadian IPO bell!
Yesterday I had no idea if I would sell today. I decided to do nothing and I am very happy about it.
$CWEB/$CWBHF!
O Canada
It was PR day it seems, I love the Charlotte!
Very nice!
Very bullish CWEB.c chart:
https://ih.advfn.com/stock-market/CNSX/CWEB/chart?_ga=2.168015137.1059032393.1535146494-2147040779.1527005978
Epic breakout coming soon imo. It might break 18.50$ cad before the end of the week!
Half of my shares are for sale at 75$.
Market loves the news here!
30min candles with 50ma, bulls are in full control!
https://en.wikipedia.org/wiki/Clay_animation
NITE on bid.
10k at 003
It's back!
Big bid gone?
It touched 0.0074$ yesterday and 0.0034$ today...
Leading market share of 14% in the U.S. market.
Charlotte's Web produces and distributes hemp-based CBD products with a leading market share of 14% in the U.S. market.
The company is highly profitable and has grown tremendously to reach significant scale with Q2 revenue of $17.2 million.
This stock is a core holding for cannabis investors that are looking for CBD-focused plays and diversify away from THC-only stocks.
Ah I see, it is not the first time Eddie knows before the counter.
Please do not apologize. I was expecting such a pop, but perhaps I've been wishing to get lucky a bit too much.
I think SEC having no further comments makes me happy.
Yes I saw the vampires, it seems the blood got more interesting. I have some garlic I could throw around. I like the "other shell zombie" neck of the woods. Impressive donkey prophecies imo.
Which led me to this person who has an impressive education.
https://www.bloomberg.com/research/stocks/people/person.asp?personId=532910952&privcapId=26365707
And I had to see this:
Corriente Master Fund II, LP Announces Current Holdings of Shares in Charlotte's Web Holdings, Inc.
TORONTO, Sept. 6, 2018 /CNW/ - Corriente Master Fund II, LP announced today it has acquired on September 4, 2018, 700,000 common shares at an average price of C$11.45 per share (the "Common Shares") in the capital of Charlotte's Web Holdings, Inc. (the "Issuer") through acquisitions on the Canadian Securities Exchange (the "CSE"). Prior to this acquisition, Corriente Master Fund II, LP owned an aggregate amount of 1,449,700 Common Shares of the Issuer, representing approximately 8.41% of the total outstanding Common Shares in the capital of the Issuer and approximately 1.56% of the total voting rights of the Issuer. Post this acquisition, Corriente Master Fund II, LP (as of September 4, 2018) owns an aggregate amount of 2,149,700 Common Shares of the Issuer, representing approximately 12.46% of the total outstanding Common Shares in the capital of the Issuer and approximately 2.32% of the total voting rights of the Issuer. Corriente Advisors, LLC is the investment manager of Corriente Master Fund II, LP. Corriente Master Fund II, LP has acquired the Common Shares for investment purposes, and may acquire further Common Shares or dispose of its holdings of the Common Shares, as investment conditions warrant. The Issuer is listed on the CSE under the symbol "CWEB".
They do both come from the same plant family but give different products. You're right there.
Apples and oranges both come from trees and give different products. Which maybe was not the best example. :P
Could we compare the cannabis plant with dogs? Indica would be a golden labrador, sativa a black labrador, ruderalis a wild dog and hemp a poodle?
CWBHF is the leader in the CBD industry.
I am 100% for the legalization of THC.
Almost literally apples and oranges.
A bit of CBD history:
A brief explanation and history of CBD
CBD reacts differently with the endocannabinoid system—the system in the brain and nervous system that manages pain-sensation, memory, mood and more—than it’s cousin THC. Whereas THC binds directly to the system’s cannabinoid receptors to stimulate things like dopamine production, CBD reacts indirectly with the receptors and increases the body’s production of naturally-produced endocannabinoids.
With the sudden rush of attention around CBD in recent years, one could be forgiven for thinking that it’s a new discovery. In reality, CBD was first isolated from the cannabis plant all the way back in 1940. However, it would be a long time before we came to understand its potential. As with any medicinal drug, and particularly with one associated with cannabis, the road to understanding and legitimacy has been long and slow for CBD.
Dr. Roger Adams and a team of chemists at the university of Illinois were the first to discover the compound, though based on the paper that the team published in 1940, it’s clear that Adams and his team had no idea what they had discovered. The paper described CBD as “very toxic,” something we now know to be far from the truth.
It would take until 1963 for researchers to take another serious look at CBD when Dr. Raphael Mechoulam of the Hebrew University of Jerusalem determined the compound’s exact structure, opening CBD up for research as a pharmacological substance. In 1973, the first suggestions of CBD’s therapeutic potential were made when Brazilian researchers found reductions of the symptoms of epilepsy in animals. Further studies over the following two decades yielded promising results, showing a diminishment of convulsions in epilepsy patients, and promise for treating psychosis and anxiety. The discovery of the endocannabinoid system in 1988 shed light on how cannabinoids naturally work with the human body and further increased interest in cannabinoids as therapeutic medicine.
This research continued into the 21st century but it would be the plight of a little girl in Colorado that would bring the compound to mainstream attention. The high CBD/low THC cannabis strain Charlotte’s Web was developed in 2011 and named for Charlotte Figi, a then five-year-old girl with Dravet Syndrome, who was suffering from up to 300 grand mal seizures each week. As numerous other medications and therapies failed to help and Charlotte’s quality of life rapidly declined, her parents turned to CBD, a treatment that was unheard of for children at the time and extremely controversial. To the astonishment of Charlotte’s parents and physicians, the hail mary treatment did in fact reduce her seizures, completely.
Charlotte’s story attracted serious media attention from outlets all over the world, bringing attention and education on medicinal CBD to the public. Since then, the market for CBD products has exploded. CBD is now commonly used for serious disorders like Charlotte’s, for chronic pain and ailments, and as a general health and wellness product.
CWBHF: best-known public hemp companies
Based in Colorado and produced by the Stanley Brothers, CW Hemp Inc. (CNSX: CWEB) is among the best-known public hemp companies in the United States. The company, originally known as Stanley Brothers Inc., first gained national attention in 2013 after developing a high CBD strain of cannabis known as Charlotte's Web (which helped treat epileptic seizures for a young girl named Charlotte Figi). Since then, the company has positioned itself as a manufacturer and supplier of hemp-derived CBD oil, and has rebranded itself as CW Hemp. Most recently, the company found itself in the spotlight again after it quietly raised $100 million in one of the largest initial public offerings in hemp history.
The projection is that CWBHF will outperform the industry average growth rate
Canaccord is forecasting a CAGR of 91 percent over the next three years (EBITDA of $28 million, $59 million and $99 million in 2018, 2019 and 2020, respectively). The projection is that Charlotte’s Web Holdings will outperform the industry average growth rate. Canaccord cites the company’s strong brand positioning, vertical integration and retail presence among other assets that make it attractive to investors. Here are their key investment highlights.
Ibuprofen=advil, Acetaminophen=tylenols, CBD=Charlotte's Web
CWBHF will make us all rich bitches!
jmho
Best high CBD strain for autism: Charlotte’s Web:
The ultimate medical strain with high CBD levels and almost no psychoactive THC (less than 0.3 percent). Cannabis breeders, The Stanley Brothers developed this strain to help a girl called Charlotte Figi, who was suffering from severe epileptic seizures. This strain does not cause psychoactive effects and parents who use it (usually as edibles) for treating their children’s autism symptoms report seeing improvement in appetite and demeanour.
Another CWBHF artcle:
The supermarket chain sells a line of hemp oil extract products called Charlotte’s Web and two representatives of the company presented at the workshop.
the most famous being 'Charlotte's Web'.
Bah how to explain anything to "investors" who don't understand how a share structure works?!
It's like trying to explain to a taxi driver where the gas pedal is.
CWBHF sales: 40m
other company sales: 27m
CWBHF weighted avg common shares basic: 8'805'000
other company weighted avg common shares basic: 90,712,929
CWBHF
https://backend.otcmarkets.com/otcapi/company/financial-report/203712/content
other company
https://www.otcmarkets.com/filing/html?id=12886199&guid=16nZU6EEmuxEO3h
Competitors make generic CBD wishing to be as effective as Charlotte's Web.
+ CWBHF has a tiny float! <3
CRANBURY, N.J. and Mendoza, ARGENTINA, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced additional positive results from a global Phase 1/2 clinical study (ATB200-02) to investigate AT-GAA in patients with Pompe disease, an inherited lysosomal storage disorder caused by an enzyme deficiency that leads to accumulation of glycogen (disease substrate) in cells. Patients treated with AT-GAA for up to 18 months showed improvements in six-minute walk test (6MWT) distance and other measures of motor function and muscle strength, stability or increases in forced vital capacity (FVC), and durable reductions in biomarkers of muscle damage and disease substrate. These clinical results are being featured at the 23rd International Annual Congress of the World Muscle Society in an oral platform presentation today, Friday October 5, 2018 at 12:20am ART (11:20am EDT).
The presentation will be given by Professor Benedikt Schoser, senior consultant at the Friedrich-Baur-Institute, Dept. of Neurology at the Ludwig-Maximilians-University of Munich, Germany and Principal Investigator in the ATB200-02 study.
CWBHF on Dr. Oz
This shows how much Charlotte's Web is already a brand name in the CBD community imo. They were discussing the multiple benefits of using CBD medically, and they mentioned Charlotte's Web.
Brand Name CBD, 2nd biggest revs in cannabis industry, the potential for growth here is enormous imo.
OS 82m?
Pink tomorrow?
https://www.theglobeandmail.com/investing/markets/stocks/EPW-CN/
#Chicago residents: we're excited to have clinic openings starting next week! 10/10, 10/13 and 10/15 - times vary. Call 888-EMPOWER to schedule you appt! pic.twitter.com/sN1gAVDM6F
— Empower Clinics (@EmpowerClinics) October 4, 2018
Post this acquisition, Corriente Master Fund II, LP (as of September 4, 2018) owns an aggregate amount of 2,149,700 Common Shares of the Issuer, representing approximately 12.46% of the total outstanding Common Shares in the capital of the Issuer and approximately 2.32% of the total voting rights of the Issuer.
Data dates are sept2, sept16, sept30.
I am not an expert in short data.
ACB 160m shorts?
https://shortdata.ca/stock/ACB.TO/